Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ETON
ETON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ETON News
FDA Approves Zycubo for Pediatric Menkes Disease Treatment
Jan 28 2026
NASDAQ.COM
Eton Pharmaceuticals to Host Investor Meeting at Piper Sandler Healthcare Conference in NYC
Nov 24 2025
Newsfilter
Eton Pharmaceuticals to Attend the 16th Annual Craig-Hallum Alpha Select Conference on November 18th
Nov 12 2025
Newsfilter
Eton Pharma (ETON) Third Quarter 2025 Earnings Call Transcript
Nov 09 2025
NASDAQ.COM
Eton Pharmaceuticals Stock Options Experience a Surge in Implied Volatility
Sep 22 2025
NASDAQ.COM
Eton Pharmaceuticals to Attend the 2025 Wells Fargo Healthcare Conference
Aug 20 2025
Newsfilter
FDA Accepts Eton Pharma's NDA For ET-600 Desmopressin Oral Solution
Jul 08 2025
NASDAQ.COM
Eton gains as hormonal disorder therapy undergoes FDA review
Jul 08 2025
SeekingAlpha
Eton Pharmaceuticals Added to Russell 3000® and Russell 2000® Indexes as Part of 2025 Reconstitution
Jun 27 2025
NASDAQ.COM
FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue
May 29 2025
Benzinga
FDA Approves Eton Pharma's KHINDIVI For Pediatric Adrenocortical Insufficiency
May 29 2025
NASDAQ.COM
A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts
May 14 2025
Benzinga
Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $28
May 14 2025
Benzinga
Eton Pharmaceuticals Secures Major Revenue Growth In Q1, Launches ET-400 In Sight
May 14 2025
NASDAQ.COM
Q1 2025 Eton Pharmaceuticals Inc Earnings Call
May 14 2025
Yahoo Finance
After-Hours Earnings Report for May 13, 2025 : ALC, EXEL, CAE, OKLO, DAC, SMWB, DDI, GAIN, ETON, ZVRA, SKYH, CLPT
May 13 2025
NASDAQ.COM
Show More News
